首页> 外文学位 >Quantitation of pharmaceutical formulations and monitoring of pharmaceutical processes using process analytical technology techniques: Near infrared and Raman spectroscopy.
【24h】

Quantitation of pharmaceutical formulations and monitoring of pharmaceutical processes using process analytical technology techniques: Near infrared and Raman spectroscopy.

机译:使用过程分析技术技术对药物制剂进行定量和药物过程监控:近红外和拉曼光谱。

获取原文
获取原文并翻译 | 示例

摘要

This research was aimed at contributing to the Food and Drug Administration's process analytical technology (PAT) initiative that is intended to monitor pharmaceutical processes and pharmaceutical formulations ensuring the safety and efficacy of the end product. PAT tools of near infrared (NIR) and Raman spectroscopy have been adapted to aid in this study. Continuous processes of hot melt extrusion and hydrogenation reactions were monitored using these tools. Hot melt extruded films were monitored for the active ingredient both offline and online using NIR/Raman spectroscopy. The amount of dexamethasone and theophylline was determined in immediate release pellet formulations using NIR spectroscopic method. Cannabis sativa matrices were investigated for the amount of Delta9-tetrahydrocannabinol (THC) and also quantitation of THC was performed in hot-melt films using NIR spectroscopy.;The first objective of this research was to demonstrate the utility of NIR spectroscopy for quantitative analysis of a model drug in a two-component system of hot-melt extruded (HME) film formulations. The NIR method developed resulted in an assayed clotrimazole amount in the film matrix to be with in 3.5 % of the quantity determined by the reference method. These studies clearly demonstrate that NIR spectroscopy is a powerful tool for the quantitation of active drug substances contained in films produced by HME.;The other formulation category that was investigated to assess the utility of these PAT tools was immediate release pellet formulations. NIR spectroscopy was utilized for the quantitative and qualitative analysis of an active ingredient in pellet formulations. Theophylline and Dexamethasone were used as the active pharmaceutical ingredients (APIs) in the pellet formulations. In both the cases, pellets with contents varying from 2% to 20% of the respective API were prepared. The prediction error ranged from--0.29 to +0.60% for dexamethasone and -0.56 to +0.63% for theophylline. It can be inferred from the narrow window of the % error in both the cases that NIR can be a good alternative to UV method, which is a time-consuming means of laboratory analyses for these types of formulations.;It has been a challenge to investigate the utility of NIR spectroscopy for the quantitative analysis of an active like THC in dry marijuana plant leaves. Marijuana consists of about 400 other cannabinoids along with THC. This study was aimed at the applicability of NIR in a multi-component matrix. Samples from different lots of cannabis sativa containing 3.74 -- 16.94% THC were used for the calibration model. NIR spectra of the marijuana samples from 10000 -- 4000 cm-1 were obtained using a Bruker FT-IR spectrophotometer, which was also used in previous experiments. Chemometrics was applied using OPUS/QUANT2 version 2.2 software and partial least squares algorithm was used for the calibration models. A sample set of 55 was used as the training set and 50 samples were used for validation. All the samples used for both of calibration and the validation set were assayed using the standard gas chromatography (GC) reference method. The linear regression of the final calibration model yielded a R2 of 0.97 with a root mean square error of 0.75. No spectral preprocessing was performed for this model. The root mean square error of prediction was found to be 2.01. The amount of THC predicted in the cannabis sativa samples was determined to be within 5% of the value obtained using the GC reference method. This research was then extended to determine the amount of THC in film dosage forms. Solid dispersions of THC-PEO containing 0 -- 15% w/w of the drug were punched into circular polymeric matrices utilizing a hot-melt punch method. NIR spectra were obtained for all of these formulations in the entire range of 12,500 -- 4000 wavenumbers. Calibration set consisted of 0, 5, 10 and 15% THC films and the test set comprised of 2.5, 7.5 and 12.5% THC films. A very good correlation was found between the amount of THC estimated in these films using NIR model and the value obtained using HPLC analysis. (Abstract shortened by UMI.)
机译:这项研究旨在为食品和药物管理局的过程分析技术(PAT)计划做出贡献,该计划旨在监控制药过程和药物制剂,以确保最终产品的安全性和有效性。近红外(NIR)和拉曼光谱的PAT工具已经过调整,以协助进行这项研究。使用这些工具监测热熔挤出和氢化反应的连续过程。使用NIR /拉曼光谱仪离线和在线监测热熔挤出薄膜的活性成分。使用NIR光谱法测定速释微丸制剂中地塞米松和茶碱的含量。研究了大麻基体中Delta9-四氢大麻酚(THC)的量,并使用近红外光谱法在热熔膜中进行了四氢大麻酚的定量分析;该研究的第一个目的是证明近红外光谱法可用于定量分析热熔挤出(HME)薄膜配方两组分系统中的模型药物。所开发的NIR方法导致薄膜基质中克霉唑的含量测定为参考方法测定含量的3.5%。这些研究清楚地表明,NIR光谱是定量HME生产的薄膜中所含活性药物的有力工具。被研究用来评估这些PAT工具效用的另一种制剂类别是速释微丸制剂。 NIR光谱用于颗粒制剂中活性成分的定量和定性分析。茶碱和地塞米松被用作颗粒制剂中的活性药物成分(API)。在这两种情况下,均制备了各自API含量在2%至20%之间的颗粒。地塞米松的预测误差范围为--0.29至+ 0.60%,茶碱的预测误差范围为-0.56至+ 0.63%。在两种情况下都可以从%误差的狭窄窗口推断出NIR可以很好地替代UV方法,这是对这类制剂进行实验室分析的一种费时的方法。 NIR光谱研究了大麻干植物叶片中活性成分THC定量分析的实用性。大麻由大约400种其他大麻素以及四氢大麻酚组成。这项研究的目的是在多组分基质中近红外的适用性。校准模型使用了来自不同批次大麻的,含有3.74-16.94%THC的样品。使用布鲁克FT-IR分光光度计获得了10000-4000 cm-1的大麻样品的近红外光谱,该光谱也用于先前的实验中。化学计量学是使用OPUS / QUANT2 2.2版软件应用的,并且偏最小二乘算法用于校准模型。使用55个样本集作为训练集,并使用50个样本进行验证。使用标准气相色谱(GC)参考方法分析了用于校准和验证集的所有样品。最终校准模型的线性回归得出R2为0.97,均方根误差为0.75。此模型未执行光谱预处理。发现预测的均方根误差为2.01。大麻样本中预测的四氢大麻酚含量确定为使用GC参考方法获得的值的5%以内。然后将这项研究扩展到确定薄膜剂型中四氢大麻酚的含量。使用热熔冲压法将含有0-15%w / w药物的THC-PEO固体分散体冲压成圆形聚合物基质。在所有12,500-4000波数范围内,所有这些配方均获得了NIR光谱。校准套件由0%,5%,10%和15%的THC薄膜组成,而测试套件由2.5%,7.5%和12.5%的THC薄膜组成。在使用NIR模型估算的这些薄膜中的THC量与通过HPLC分析获得的值之间发现了很好的相关性。 (摘要由UMI缩短。)

著录项

  • 作者

    Tumuluri, Venkat S.;

  • 作者单位

    The University of Mississippi.;

  • 授予单位 The University of Mississippi.;
  • 学科 Health Sciences Pharmacology.;Chemistry Pharmaceutical.
  • 学位 Ph.D.
  • 年度 2007
  • 页码 205 p.
  • 总页数 205
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 11:40:31

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号